Sorafenib Completed Phase 1 Trials for Prostate Cancer / Colorectal Cancers / Mesothelioma / Sarcomas / Lung Cancers / Breast Cancer / Malignant Neoplasm of Pancreas / Head and Neck Carcinoma Treatment

CompletedTreatment1 IdentifierTitleDrugs
NCT00703638Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT00424385Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
NCT00533585BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)
NCT00822848Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
NCT00789763Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma